RecruitingMigraineMigraine With AuraMigraine Without Aura
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Sponsor: University of Florence
You may qualify if…
- ✓ Diagnosis of migraine without aura or migraine with aura, according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III);
- ✓ At least 4 monthly migraine days;
- ✓ Good compliance to study procedures;
- ✓ Availability of headache diary at least of the preceding months before enrollment.
You may not qualify if…
- ✕ Subjects with contraindications for use of gepants;
- ✕ Diagnosis of chronic migraine
- ✕ Concomitant diagnosis of medical diseases and/or comorbidities that, in the Investigator's opinion might interfere with study assessments;
- ✕ medical comorbidities that could interfere with study results;
- ✕ Pregnancy and breastfeeding.
- ✕ Changes in preventive treatments in the month before the first administration of rimegepant
Source: ClinicalTrials.gov · NCT06409832 · last updated 2026-06-11